North America Peptide Therapeutics Market Size & Outlook

The peptide therapeutics market in North America is expected to reach a projected revenue of US$ 172,089.8 million by 2030. A compound annual growth rate of 16% is expected of North America peptide therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$54,097.3
Forecast, 2030 (US$M)
$172,089.8
CAGR, 2024 - 2030
16%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America peptide therapeutics market, 2018-2030 (US$M)

North America peptide therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America peptide therapeutics market highlights

  • The North America peptide therapeutics market generated a revenue of USD 54,097.3 million in 2023.
  • The market is expected to grow at a CAGR of 18% from 2024 to 2030.
  • In terms of segment, metabolic disorders was the largest revenue generating application in 2023.
  • Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 54,097.3 million
Market revenue in 2030USD 172,089.8 million
Growth rate18% (CAGR from 2023 to 2030)
Largest segmentMetabolic disorders
Fastest growing segmentMetabolic disorders
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer, Metabolic disorders, Cardiovascular disorders, Respiratory disorders, Gastrointestinal disorders, Infectious disease, Pain, Dermatological disorders, Neurological disorders, Renal disorders
Key market players worldwideEli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health


Other key industry trends

  • In terms of revenue, North America region accounted for 57.6% of the global peptide therapeutics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 172,089.8 million by 2030.

Metabolic disorders was the largest segment with a revenue share of 59.46% in 2023. Horizon Databook has segmented the North America peptide therapeutics market based on cancer, metabolic disorders, cardiovascular disorders, respiratory disorders, gastrointestinal disorders, infectious disease, pain, dermatological disorders, neurological disorders, renal disorders covering the revenue growth of each sub-segment from 2018 to 2030.


North America leads the global peptide therapeutics market in terms of revenue generation, owing to the launch of effective products along with technologically advanced production facilities across the region. In addition, the increasing prevalence of diseases, such as cancer, cardiovascular disorders, respiratory diseases, infectious diseases, metabolic disorders, and others, is expected to drive market growth.

A large population is prone to major target diseases, which increases the need to develop effective therapeutics to curb their prevalence and enable effective management. Key players operating in the market are constantly focusing on product launches, collaborations, and partnerships to meet the rising demand among the population.

Both companies have been long-term partners of PeptiDream. Furthermore, the market in the region is anticipated to grow due to rising investments in the R&D of novel drugs and technological advancements pertaining to the development of effective therapeutics.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Therapeutics Market Companies

Name Profile # Employees HQ Website
Radius Health View profile 251-500 Cambridge, Massachusetts, United States, North America http://www.radiuspharm.com
Ironwood Pharmaceuticals Inc Class A View profile 267 100 Summer Street, Suite 2300, Boston, MA, United States, 02110 https://www.ironwoodpharma.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Ipsen SA View profile 5325 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 https://www.ipsen.com
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

North America peptide therapeutics market size, by country, 2018-2030 (US$M)

North America Peptide Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

North America peptide therapeutics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online